Author:
Huang Tonghai,Ren Kangqi,Ling Xiean,Li Zeyao,Chen Lin
Funder
Natural Science Foundation of Shenzhen
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS (2021) Lung cancer. Lancet 398(10299):535–554
2. Liu L, Zhang J, Ferguson MK, Appelbaum D, Zhang JX, Pu Y (2022) Developing a clinical and PET/CT volumetric prognostic index for risk assessment and management of NSCLC patients after initial therapy. Front Biosci 27(1):16
3. Suster DI, Mino-Kenudson M (2020) Molecular pathology of primary non-small cell lung cancer. Arch Med Res 51(8):784–798
4. Jonna S, Subramaniam DS (2019) Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update. Discov Med 27(148):167–170
5. Duma N, Santana-Davila R, Molina JR (2019) Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc 94(8):1623–1640